US Patent Issued to HUAHUI HEALTH on Sept. 23 for "Anti-FGF19 antibodies" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,307, issued on Sept. 23, was assigned to HUAHUI HEALTH LTD. (Beijing).

"Anti-FGF19 antibodies" was invented by Jianhua Sui (Beijing) and Huisi Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-FGF19 antibodies that selectively target N-terminus of fibroblast growth factor 19 (FGF19) and antigen-binding fragments thereof, as well as uses of said antibodies in treating a disease or disorder caused by or related to abnormal FGF19-FGFR4 signaling, e.g., cancer."

The patent was filed on Feb. 2, 2020, under Application No. 17/427,301.

*For further information, including images, charts and tables, please visit: http://patft.u...